These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25783668)

  • 1. Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.
    Kulkarni J; Reeve-Parker K
    Australas Psychiatry; 2015 Jun; 23(3):258-64. PubMed ID: 25783668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey.
    Olivares JM; Thirunavukarasu M; Kulkarni J; Zhang HY; Zhang M; Zhang F
    Neuropsychiatr Dis Treat; 2013; 9():1163-70. PubMed ID: 23976858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
    Kim SW; Yoon JS; Choi SK
    Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa.
    Olivares JM; Alptekin K; Azorin JM; Cañas F; Dubois V; Emsley R; Gorwood P; Haddad PM; Naber D; Papageorgiou G; Roca M; Thomas P; Martinez G; Schreiner A
    Patient Prefer Adherence; 2013; 7():121-32. PubMed ID: 23390361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment.
    Markowitz MA; Levitan BS; Mohamed AF; Johnson FR; Bridges JF; Alphs L; Citrome L
    Psychiatr Serv; 2014 Sep; 65(9):1133-9. PubMed ID: 24828964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.
    Gundugurti PR; Nagpal R; Sheth A; Narang P; Gawande S; Singh V
    Asian J Psychiatr; 2017 Dec; 30():88-93. PubMed ID: 28843143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenia through the carers' eyes: results of a European cross-sectional survey.
    Svettini A; Johnson B; Magro C; Saunders J; Jones K; Silk S; Hargarter L; Schreiner A
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):472-83. PubMed ID: 25944551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
    Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
    J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disorders.
    Hamann J; Lipp ML; Christ-Zapp S; Spellmann I; Kissling W
    Psychiatr Serv; 2014 Jul; 65(7):881-7. PubMed ID: 24686753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatrists' perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries.
    Vieta E; Azorin JM; Bauer M; Frangou S; Perugi G; Martinez G; Schreiner A
    J Affect Disord; 2012 Dec; 143(1-3):125-30. PubMed ID: 22840608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatrists' self-reported adherence to evidence-based prescribing practices in the treatment of schizophrenia.
    Young GJ; Mohr DC; Meterko M; Seibert MN; McGlynn G
    Psychiatr Serv; 2006 Jan; 57(1):130-2. PubMed ID: 16399975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding or switching antipsychotic medications in treatment-refractory schizophrenia.
    Kreyenbuhl J; Marcus SC; West JC; Wilk J; Olfson M
    Psychiatr Serv; 2007 Jul; 58(7):983-90. PubMed ID: 17602016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.
    Eticha T; Teklu A; Ali D; Solomon G; Alemayehu A
    PLoS One; 2015; 10(3):e0120560. PubMed ID: 25816353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs.
    Laugharne J; Waterreus AJ; Castle DJ; Dragovic M
    Australas Psychiatry; 2016 Feb; 24(1):62-6. PubMed ID: 26635377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
    Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
    Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatrists' psychotropic drug prescription preferences for themselves or their family members.
    Latas M; Stojkovic T; Ralic T; Milovanovic S; Jasovic-Gasic M
    Psychiatr Danub; 2012 Jun; 24(2):182-7. PubMed ID: 22706417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.